195 related articles for article (PubMed ID: 31608617)
1. Ovarian Metabolic activity in Dehydroepiandrosterone-Induced Polycystic Ovary in Wistar rats Treated with Aspirin.
Olaniyan OT; Bamidele O; Uche S; Femi A; Ayobami D; Ayoola O; Builders M; Mali PC
JBRA Assist Reprod; 2020 Jan; 24(1):41-54. PubMed ID: 31608617
[TBL] [Abstract][Full Text] [Related]
2. Quercetin modulates granulosa cell mRNA androgen receptor gene expression in dehydroepiandrosterone-induced polycystic ovary in Wistar rats via metabolic and hormonal pathways.
Olaniyan OT; Bamidele O; Adetunji CO; Priscilla B; Femi A; Ayobami D; Okotie G; Oluwaseun I; Olugbenga E; Mali PC
J Basic Clin Physiol Pharmacol; 2020 Mar; 31(4):. PubMed ID: 32160160
[TBL] [Abstract][Full Text] [Related]
3. Vitamin C suppresses ovarian pathophysiology in experimental polycystic ovarian syndrome.
Olaniyan OT; Femi A; Iliya G; Ayobami D; Godam E; Olugbenga E; Bamidele O; Chand Mali P
Pathophysiology; 2019; 26(3-4):331-341. PubMed ID: 31564389
[TBL] [Abstract][Full Text] [Related]
4. The ameliorative effects of marjoram in dehydroepiandrosterone induced polycystic ovary syndrome in rats.
Rababa'h AM; Matani BR; Ababneh MA
Life Sci; 2020 Nov; 261():118353. PubMed ID: 32877649
[TBL] [Abstract][Full Text] [Related]
5. Effects of vitamin D on ovary in DHEA-treated PCOS rat model: A light and electron microscopic study.
Çelik LS; Kuyucu Y; Yenilmez ED; Tuli A; Dağlıoğlu K; Mete UÖ
Ultrastruct Pathol; 2018; 42(1):55-64. PubMed ID: 29192811
[TBL] [Abstract][Full Text] [Related]
6. The anti-androgenic effect of quercetin on hyperandrogenism and ovarian dysfunction induced in a dehydroepiandrosterone rat model of polycystic ovary syndrome.
Mahmoud AA; Elfiky AM; Abo-Zeid FS
Steroids; 2022 Jan; 177():108936. PubMed ID: 34752810
[TBL] [Abstract][Full Text] [Related]
7. The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats.
Wu G; Hu X; Ding J; Yang J
J Ovarian Res; 2020 May; 13(1):57. PubMed ID: 32386521
[TBL] [Abstract][Full Text] [Related]
8. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study.
Furat Rencber S; Kurnaz Ozbek S; Eraldemır C; Sezer Z; Kum T; Ceylan S; Guzel E
J Ovarian Res; 2018 Jun; 11(1):55. PubMed ID: 29958542
[TBL] [Abstract][Full Text] [Related]
9. Dehydroepiandrosterone with a high-fat diet treatment at inducing polycystic ovary syndrome in rat model.
He Y; Li X; Li Y; Kuai D; Zhang H; Wang Y; Tian W
Steroids; 2024 Jun; 206():109424. PubMed ID: 38642598
[TBL] [Abstract][Full Text] [Related]
10. Effect of Hawthorn Leaf Flavonoids in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome in Rats.
Shi Y; Kong X; Yin H; Zhang W; Wang W
Pathobiology; 2019; 86(2-3):102-110. PubMed ID: 30404093
[TBL] [Abstract][Full Text] [Related]
11. Dulaglutide, a long-acting GLP-1 receptor agonist, can improve hyperandrogenemia and ovarian function in DHEA-induced PCOS rats.
Wu LM; Wang YX; Zhan Y; Liu AH; Wang YX; Shen HF; Wang YF; Wang LY; Tao ZB; Wang YQ
Peptides; 2021 Nov; 145():170624. PubMed ID: 34375684
[TBL] [Abstract][Full Text] [Related]
12. Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats.
Zhang X; Zhang C; Shen S; Xia Yj; Yi L; Gao Q; Wang Y
Hum Reprod; 2013 Nov; 28(11):3074-85. PubMed ID: 23980058
[TBL] [Abstract][Full Text] [Related]
13. DHEA-induced ovarian hyperfibrosis is mediated by TGF-β signaling pathway.
Wang D; Wang W; Liang Q; He X; Xia Y; Shen S; Wang H; Gao Q; Wang Y
J Ovarian Res; 2018 Jan; 11(1):6. PubMed ID: 29321035
[TBL] [Abstract][Full Text] [Related]
14. Androgen receptor and uterine histoarchitecture in a PCOS rat model.
Gisela S B; M Virginia A; Gabriela A A; M Virginia T; Enrique H L; Laura K; Véronica L B
Mol Cell Endocrinol; 2020 Dec; 518():110973. PubMed ID: 32781251
[TBL] [Abstract][Full Text] [Related]
15. Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome.
Li Y; Zheng Q; Sun D; Cui X; Chen S; Bulbul A; Liu S; Yan Q
J Cell Physiol; 2019 May; 234(5):7435-7447. PubMed ID: 30580448
[TBL] [Abstract][Full Text] [Related]
16. Etanercept Ameliorates Vascular, Endocrine, and Ovarian Changes in a Rat Model of DHEA-Induced Polycystic Ovary Syndrome.
Utkan Korun ZE; Gocmez SS; Furat Rencber S; Kavram Sarıhan K; Eraldemir FC; Sahin D
Reprod Sci; 2024 Mar; 31(3):714-726. PubMed ID: 37932553
[TBL] [Abstract][Full Text] [Related]
17. The use of dehydroepiandrosterone-treated rats is not a good animal model for the study of metabolic abnormalities in polycystic ovary syndrome.
Seow KM; Ting CH; Huang SW; Ho LT; Juan CC
Taiwan J Obstet Gynecol; 2018 Oct; 57(5):696-704. PubMed ID: 30342654
[TBL] [Abstract][Full Text] [Related]
18. γ-Linolenic acid ameliorates DHEA induced pro-inflammatory response in polycystic ovary syndrome via PPAR-γ signaling in rats.
D Prabhu Y; Valsala Gopalakrishnan A
Reprod Biol; 2020 Sep; 20(3):348-356. PubMed ID: 32444273
[TBL] [Abstract][Full Text] [Related]
19. Ameliorative effects of fisetin in letrozole-induced rat model of polycystic ovary syndrome.
Mihanfar A; Nouri M; Roshangar L; Khadem-Ansari MH
J Steroid Biochem Mol Biol; 2021 Oct; 213():105954. PubMed ID: 34298098
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of Bcl-2 and Bax in follicles within dehydroepiandrosterone-induced polycystic ovaries in rats.
Bas D; Abramovich D; Hernandez F; Tesone M
Cell Biol Int; 2011 May; 35(5):423-9. PubMed ID: 21062263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
